IP Library Granted Patent US 11,065,454
Granted Patent B2
US 11,065,454 · App. 15/612,236 · Granted Jul 20, 2021

Methods and systems for reducing interference in stimulation treatment

Inventors: Nicolas Fontaine (Bottens, CH); Steve Guex (Givrins, CH); Flavien Baumgartner (Vevey, CH)
Assignee: DJO, LLC
A61N1/37A61N1/3603A61N1/37288A61N1/3702A61N1/37252A61N1/37264
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,065,454
App. No.
15/612,236
Granted
Jul 20, 2021
Kind
B2
Abstract

Systems and methods are provided for reducing stimulation interference between two stimulation modules positioned on a user's body, which may be used in stimulation systems without a central treatment controller. Systems and methods are also provided for stimulation treatment using multiple independent stimulators wirelessly managed by a remote management device.

Claims (29)

1. A stimulation treatment system for reducing interference between a first stimulation program on the stimulation treatment system that is operating simultaneously with a second stimulation program on another stimulation treatment system where the first stimulation program and the second stimulation program do not use a central controller to time and coordinate the delivery of stimulation pulses, the first stimulation program comprising a succession of stimulation pulses delivered to a first body site and the second stimulation program comprising a succession of stimulation pulses delivered to a second body site, the system comprising:

a first stimulation transducer device configured with the first stimulation program to generate stimulation pulses applied at the first body site;

a first processor having communication circuitry configured to communicate with the first stimulation transducer device;

wherein the first stimulation transducer device includes circuitry that generates stimulation pulses and detects stimulation signals indicative of a stimulation pulse, the first stimulation transducer device configured to:

receive treatment information from the first processor;

monitor the first body site during a first detection period to detect the presence of a signal indicative of a stimulation pulse delivered to the user by a second stimulation transducer device configured with the second stimulation program and operating simultaneously with the first stimulation program, wherein the first stimulation transducer device is not in communication with the second stimulation transducer device to coordinate delivery of stimulation signals;

in response to not detecting the signal indicative of a stimulation pulse from the second stimulation transducer device at the first body site, deliver a stimulation pulse at the first body site in accordance with the received treatment information; and

in response to detecting the signal indicative of a stimulation pulse from the second stimulation transducer device, delay the delivery of stimulation treatment of the first stimulation transducer device for a first delay period and at the end of the first delay period, deliver a stimulation pulse at the first body site.

2. The system of claim 1 , wherein the first stimulation transducer device detects that a stimulation pulse from the second stimulation transducer device is present when the detected signal has a magnitude exceeding a pre-determined threshold.

3. The system of claim 1 , wherein the first stimulation transducer device includes circuitry that filters the signal detected during the first detection period.

4. The system of claim 1 , wherein the first stimulation transducer device includes circuitry that ascribes a priority to the signal detected during the first detection period.

5. The system of claim 1 , wherein the first stimulation transducer device includes a processor that causes a delay of the delivery of stimulation treatment by the first stimulation transducer device.

6. The system of claim 5 , further comprising a counter for storing a value indicative of a number of times that stimulation treatment is delivered by the second stimulation transducer device after delaying the delivery of stimulation treatment.

7. The system of claim 6 , further comprising a processor configured to determine when the value stored in the counter exceeds a retry limit.

8. The system of claim 7 , further comprising an electronic indicator that is triggered when the retry counter reaches a retry limit.

9. The system of claim 6 , wherein the first stimulation transducer device is further configured to transmit a signal to a management module when the value stored in the counter exceeds the retry limit.

10. The system of claim 5 , wherein first stimulation transducer device is further configured to provide a marking pulse after delaying the delivery of stimulation treatment and prior to delivery of stimulation treatment.

11. The system of claim 1 , further comprising the second stimulation transducer device, wherein the second stimulation transducer device has circuitry that generates and detects stimulation and is configured to:

receive treatment information from the first processor,

deliver electrical stimulation treatment to a user in accordance with the received treatment information,

detect a signal indicative of stimulation treatment delivered to the user at the first body site by the first stimulation transducer device, and

in response to detecting the signal, delay the delivery of stimulation treatment.

12. The system of claim 1 , wherein the communication circuitry is wireless communication circuitry.

13. The system of claim 1 , wherein the stimulation treatments comprise a succession of stimulation pulses.

14. The system of claim 1 , wherein the circuitry is further configured to monitor for the signal indicative of stimulation treatment delivered to the user by the second stimulation transducer device at predetermined intervals.

15. The system of claim 1 , wherein the first delay period comprises a first random duration.

16. The system of claim 15 , wherein the first random duration is selected from between a lower duration limit and an upper duration limit.

17. The system of claim 1 , wherein the circuitry is further configured to generate a marking pulse with the first stimulation transducer device.

18. The system of claim 1 , wherein the first stimulation transducer device is further configured to, after delaying for a first delay period and before delivering a stimulation pulse at the first body site, iteratively detect whether a signal indicative of a stimulation pulse delivered to the user by the second stimulation transducer device is present, in response to not detecting the signal indicative of a stimulation pulse from the second stimulation transducer device, deliver a stimulation pulse at the first body site in accordance with the received treatment information, and in response to detecting the signal from the second stimulation transducer device, delay the delivery of stimulation treatment of the first stimulation transducer device for another delay period.

Assignments (11)
SECURITY INTEREST Recorded Jan 3, 2024
From: DJO, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066186/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2020
From: EMPI, INC.
To: DJO, LLC
Reel/Frame 054169/0977 →
RELEASE OF SECURITY INTEREST Recorded Mar 21, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.
Reel/Frame 048665/0152 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: MACQUARIE US TRADING LLC AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.
Reel/Frame 048604/0552 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS THIRD LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.
Reel/Frame 048606/0860 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.
Reel/Frame 048598/0578 →
PATENT SECURITY AGREEMENT (TERM LOAN) Recorded Apr 23, 2018
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL, L.P.
To: MACQUARIE US TRADING LLC, AS COLLATERAL AGENT
Reel/Frame 045995/0822 →
PATENT SECURITY AGREEMENT (ABL) Recorded Apr 23, 2018
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL, L.P.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 045995/0781 →
SECOND LIEN PATENT SECURITY AGREEMENT Recorded Mar 30, 2018
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL, L.P.
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045790/0761 →
THIRD LIEN PATENT SECURITY AGREEMENT Recorded Mar 30, 2018
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL, L.P.
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 046388/0531 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2017
From: FONTAINE, NICOLAS; GUEX, STEVE; BAUMGARTNER, FLAVIEN
To: EMPI, INC.
Reel/Frame 043892/0930 →